It’s the first FDA approval for a pain medication in 25 years. How does the drug work, and who is it for?

Recursion Pharmaceuticals struggles with validation of REC-994 and competition in oncology. Read why RXRX stock is a hold ...

Getting hooked on self-help books can have both positive and negative outcomes. Knowing when to break the habit of fixing ...

Price Index leapt up in the first month of 2025, ending a string of declines that began in August 2024 but retraced slightly ...

alleging that for years it “knowingly” filled millions of prescriptions — including for excessive amounts of opioids — without a concrete medical reason for doing so. In response ...